Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
06/15/2005 | EP1539748A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors |
06/15/2005 | EP1539742A1 Indole derivatives useful as histamine h3 antagonists |
06/15/2005 | EP1539741A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
06/15/2005 | EP1539738A1 Novel aryl- 4-halo-4- heteroarylmethylamino)-methyl]-piperidin-1-yl -methanone derivatives, methods for production and use thereof as medicaments |
06/15/2005 | EP1539737A1 Aroyl-piperidine derivatives |
06/15/2005 | EP1539736A1 Substituted 1,4-pyrazine derivatives |
06/15/2005 | EP1539732A1 Novel compounds |
06/15/2005 | EP1539729A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
06/15/2005 | EP1539714A2 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
06/15/2005 | EP1539707A1 Method and compounds for promoting healing and reducing inflammation |
06/15/2005 | EP1539701A1 Caspase inhibitors and uses thereof |
06/15/2005 | EP1539700A1 8-hydroxy quinoline derivatives |
06/15/2005 | EP1539697A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
06/15/2005 | EP1539696A2 Process for preparing quinolin antibiotic intermediates |
06/15/2005 | EP1539695A1 N-4-piperidinyl compounds as ccr5 modulators |
06/15/2005 | EP1539694A1 2,3-dihydro-isoindol-1-ones with mao-b inhibiting activity |
06/15/2005 | EP1539693A1 Cannabinoid receptor agonists |
06/15/2005 | EP1539687A1 Substituted glycine derivatives for use as medicaments |
06/15/2005 | EP1539683A2 Phenol derivatives and their use as rotamase inhibitors |
06/15/2005 | EP1539679A2 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
06/15/2005 | EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
06/15/2005 | EP1539674A1 Amino-propanol derivatives |
06/15/2005 | EP1539662A1 Cannabinoid receptor ligands |
06/15/2005 | EP1539284A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
06/15/2005 | EP1539216A2 Labelled somatostatin analogs backbone cyclized through metal complexation |
06/15/2005 | EP1539208A2 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
06/15/2005 | EP1539205A1 Method for the preparation of phytoprogestogenic extracts from rhizoma ligusticum chuanxiong and uses thereof |
06/15/2005 | EP1539172A1 New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno[2,3-d]pyrimidine |
06/15/2005 | EP1539170A2 Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof |
06/15/2005 | EP1539169A2 Amyotrophic lateral sclerosis treatment with cyclooxygenase-2 inhibitors |
06/15/2005 | EP1539168A2 Treatment of neuropathic pain with 6h-pyrrolo(3,4-d)pyridazine compounds |
06/15/2005 | EP1539166A1 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
06/15/2005 | EP1539165A1 Sustained-release tablet composition comprising a dopamine receptor agonist |
06/15/2005 | EP1539160A1 Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders |
06/15/2005 | EP1539149A2 Mglu receptors antagonists for treating disorders associated with mglu receptors including addiction and depression |
06/15/2005 | EP1539148A2 Bicifadine formulation |
06/15/2005 | EP1539142A2 Use of an amyloid beta vaccination in combination with a selective cox-2 inhibitor for the treatment of alzheimer s disease |
06/15/2005 | EP1539137A1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
06/15/2005 | EP1539135A1 Treatment of dyskinesia |
06/15/2005 | EP1539126A1 Pharmaceutical formulations of modafinil |
06/15/2005 | EP1539115A1 Methods and dosage forms for controlled delivery of paliperidone |
06/15/2005 | EP1538927A1 Fruit and/or vegetable derived composition |
06/15/2005 | EP1538913A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
06/15/2005 | EP1439831B1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect |
06/15/2005 | EP1435937B1 Composition comprising paracetamol and a bitterness masking component |
06/15/2005 | EP1373240B1 Retinoid x receptor modulators |
06/15/2005 | EP1368337B1 Piperazine derivatives and their use as 5-ht1b ligands |
06/15/2005 | EP1345609B1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
06/15/2005 | EP1341764B1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
06/15/2005 | EP1330255B1 Preparation of cimicifuga racemosa for treating incontinence |
06/15/2005 | EP1326866B1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines |
06/15/2005 | EP1325007B1 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
06/15/2005 | EP1299107B1 Highly concentrated stable meloxicam solutions |
06/15/2005 | EP1278740B1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
06/15/2005 | EP1261345B1 Herbal supplement for cognitive related impairment due to estrogen loss |
06/15/2005 | EP1257277B1 New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent |
06/15/2005 | EP1251856B1 Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices |
06/15/2005 | EP1251841B1 Camphor aqueous solution for treating degenerative or autoimmune diseases and as immunomodulatory agent |
06/15/2005 | EP1248785B1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
06/15/2005 | EP1244625B1 4-pyridinyl-n-acyl-l-phenylalanines |
06/15/2005 | EP1212420B1 Conditional immortalisation of cells |
06/15/2005 | EP1163241B1 Zolpidem salts |
06/15/2005 | EP1104412B1 Tace inhibitors |
06/15/2005 | EP1075270B1 Short peptide for treatment of neurological degenerative diseases |
06/15/2005 | EP1061923B1 Metal chelators for use in the treatment of alzheimer's disease |
06/15/2005 | EP0991654B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
06/15/2005 | CN1628116A Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
06/15/2005 | CN1628115A 哌啶衍生物 Piperidine derivatives |
06/15/2005 | CN1628113A Substituted indoles as alpha-1 agonists |
06/15/2005 | CN1628109A Novel aryl- and heteroarylpiperazines |
06/15/2005 | CN1628103A Pyrimidine derivitive |
06/15/2005 | CN1628102A Pyridineamido derivatives as inhibitors of monoamine oxidase (MAO-B) |
06/15/2005 | CN1628101A 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6 |
06/15/2005 | CN1628100A Gamma secretase inhibitors |
06/15/2005 | CN1627970A Safety shield system for prefilled syringe |
06/15/2005 | CN1627954A Pharmaceutical compsn. contg. extract from barleria prionitis linn and its process of prepn |
06/15/2005 | CN1627951A Compositions and method for prophylaxis and treatment of aphthous ulcers and herpes simplex lesions |
06/15/2005 | CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
06/15/2005 | CN1627943A New usage of dl-THP |
06/15/2005 | CN1627940A Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease |
06/15/2005 | CN1626545A Compound extracted from hull and stem of yellow horn, extracting method and application |
06/15/2005 | CN1626532A Amide compounds |
06/15/2005 | CN1626245A New application of chromaffin cell of adrenal medulla or opium peptide energy cell |
06/15/2005 | CN1626238A Composition of multiple scattered mixture contg.polypeptide and its pharm compsn. |
06/15/2005 | CN1626231A Chinese traditional medicine of diathermic tincture prepared from snake in use for activating blood, removing blood stasis, diminishing inflammation and relieving pain |
06/15/2005 | CN1626223A Corypalis tablet and preparation method |
06/15/2005 | CN1626222A Formula of tea dispelling the effects of alcohol and preparation method |
06/15/2005 | CN1626208A Preparation of fleabane and preparation method |
06/15/2005 | CN1626204A 'Jinqukang' oral liquid |
06/15/2005 | CN1626199A Powder injection preparation for generating channels and vessels, and preparation method |
06/15/2005 | CN1626191A Preparation of Chinese traditional medicine for enhancing and consolidating memory |
06/15/2005 | CN1626188A Health product for enhancing immunity and soothing the nerves |
06/15/2005 | CN1626184A Combined Chinese traditional medicine for strengthening immunity, anti virus, dispeling the effects of alcohol and preventing influenza and catch cold |
06/15/2005 | CN1626167A Ginseng-scorpion medicinal wine for activating the channels and alleviating pain |
06/15/2005 | CN1626154A Method for preparing liquid for sleep peacefully and relieving restlessness |
06/15/2005 | CN1626152A Medication for treating ache |
06/15/2005 | CN1626151A Medication for treating convulsion and falling sickness |
06/15/2005 | CN1626144A Medication for treating headache |
06/15/2005 | CN1626127A Combination of Chinese traditional medicine for treating sleep disorder |
06/15/2005 | CN1626125A Medication for treating sleep disorder |